Atlas Trials

MaaT Pharma

10 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch MaaT Pharma

RecordFirmDate
Oral Pooled Fecal Microbiotherapy to Prevent Allogeneic Hematopoietic Cell Transplantation Complications (PHOEBUS Trial) (NCT05762211)MaaT Pharma2023-10-31
Safety and Gut Microbiota Analysis of an Oral Microbiotherapy in Patients With Amyotrophic Lateral Sclerosis (NCT05889572)MaaT Pharma2023-06-08
MaaT013 As Salvage Therapy in Ruxolitinib Refractory GI-aGVHD Patients (NCT04769895)MaaT Pharma2022-03-25
Prospective Interventional Study Exploring the Microbiota Recolonization in SR-GvHD Patients Receiving MaaT013 (NCT05017688)MaaT Pharma2021-10-06
Safety and Tolerability Evaluation of MaaT033 (NCT04150393)MaaT Pharma2020-10-20
Treatment of Steroid Refractory Gastro-intestinal Acute GVHD afteR AllogeneiC HSCT With fEcal Microbiota tranSfer (NCT03359980)MaaT Pharma2018-08-13
Evaluation of Heterologous Fecal microbiotA Transfer in ICU Patients: a FeasibilitY and SafetY StudY (NCT03350178)MaaT Pharma2018-01-15

Track MaaT Pharma automatically

Every clearance here is in the API, with alerts when new ones post.